Ann: PharmAust Raises $2.5m via Placement, page-61

It's been long my growing suspicion (that's all it is) that the majors are being difficult with the doggie cancer discussions, not because of efficacy, but as others have already said, it might contradict their more expensive and perhaps profitable chemo treatments. This is the problem with majors, you get oligopoly and we all know about that. Hence, I think one of the major drivers for the Human mnd program was to get around this - and for a long time Richard Mollard was working secretly behind the scenes in the lab long before the original FightMND announcement. Let's hope we get good enough results to move on.

btw if things get really financially difficult way down the track, and we continue to hit a brick wall on the doggies program and the human mnd alternative proves a fizzer, we could, if things look dire, consider selling all the doggie cancer IP in an auction to the majors to raise money for continuing the human programs of this company. But I'd leave that as just a thought for way down the track and perhaps a cr or two into the future if things start looking really dire. Cheers